Unger W, Toifl K, Böhm M P, Bayer P M
Eur Neurol. 1983;22(1):65-9. doi: 10.1159/000115538.
Adenylate kinase activity was measured in 41 samples of cerebrospinal fluid in 34 patients with various neurological disorders or psychiatric symptomatologies. Activities of the enzyme showed to be linked to clinically estimated acuteness or progression of the changes in the central nervous system at the time of specimen collection. The findings suggest the conclusion that determination of adenylate kinase activity in cerebrospinal fluid is a meaningful tool for the evaluation of progression and/or acuteness of central nervous system disorders.
对34例患有各种神经系统疾病或精神症状的患者的41份脑脊液样本进行了腺苷酸激酶活性测定。在采集样本时，该酶的活性显示与临床估计的中枢神经系统变化的急性程度或进展有关。这些发现表明，脑脊液中腺苷酸激酶活性的测定是评估中枢神经系统疾病进展和/或急性程度的一个有意义的工具。
